NTRK3 and colorectal carcinoma: Our results suggest that TrkC may contribute to higher invasive recurrence risk of CRC through overexpression of TrkC mRNA, consistent with previous report that 14 of 17 patients with CRC were found coexpression of TrkC/NT-3 by immunohistochemical analysis and TrkC was related with metastasis [19].